{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:40:18Z","timestamp":1738284018520,"version":"3.35.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,7,10]],"date-time":"2008-07-10T00:00:00Z","timestamp":1215648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s10620-008-0384-x","type":"journal-article","created":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T14:54:26Z","timestamp":1215615266000},"page":"2999-3006","source":"Crossref","is-referenced-by-count":3,"title":["Predictive Factors Associated with the Progression to Hepatic Failure Caused by Lamivudine-Resistant HBV"],"prefix":"10.1007","volume":"53","author":[{"given":"Reiichiro","family":"Kuwahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryukichi","family":"Kumashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruko","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Hisamochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Takao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Sata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,10]]},"reference":[{"key":"384_CR1","first-page":"1773","volume":"337","author":"WH Lee","year":"1997","unstructured":"Lee WH (1997) Hepatitis B infection. N Engl J Med 337:1773\u20131745","journal-title":"N Engl J Med"},{"key":"384_CR2","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0016-5085(88)90367-8","volume":"95","author":"JH Hoofnagle","year":"1988","unstructured":"Hoofnagle JH, Peter M, Mullen KD, Jones DB, Rustgi V, Bisceglie AD, Hallahan C, Park Y, Meschivitz C, Jones EA (1988) Randomised controlled trial of recombinant \u03b1-interferon in patients with chronic hepatitis B. Gastroenterology 95:1318\u20131325","journal-title":"Gastroenterology"},{"key":"384_CR3","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/0016-5085(93)91082-S","volume":"105","author":"ASF Lok","year":"1993","unstructured":"Lok ASF, Chung H-T, Liu VWS, Ma OCK (1993) Long-term follow-up of chronic hepatitis B patients treated with interferon alpha. Gastroenterology 105:1833\u20131838","journal-title":"Gastroenterology"},{"key":"384_CR4","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1053\/gast.1997.v113.pm9352870","volume":"113","author":"DT-Y Lau","year":"1997","unstructured":"Lau DT-Y, Everhart J, Kleiner DE, Park Y, Vergalla J, Schmid P, Hoofnagle JH (1997) Long-term follow up of patients with chronic hepatitis B treated with interferon alpha. Gastroenterology 113:1660\u20131667","journal-title":"Gastroenterology"},{"key":"384_CR5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7326\/0003-4819-119-4-199308150-00011","volume":"119","author":"DK Wong","year":"1993","unstructured":"Wong DK, Cheung AM, O\u2019Rourke K, Naylor CD, Detsky AS, Heathcote J (1993) Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 119:312\u2013323","journal-title":"Ann Intern Med"},{"key":"384_CR6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/hep.510290312","volume":"29","author":"SM Lin","year":"1999","unstructured":"Lin SM, Sheen IS, Chien RN, Chu CM, Liaw YF (1999) Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 29:971\u2013975","journal-title":"Hepatology"},{"key":"384_CR7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/0016-5085(93)90281-G","volume":"104","author":"JH Hoofnagle","year":"1993","unstructured":"Hoofnagle JH, DiBisceglie AM, Waggoner JG, Park Y (1993) Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology 104:1116\u20131121","journal-title":"Gastroenterology"},{"key":"384_CR8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0016-5085(95)90401-8","volume":"109","author":"R Perrilo","year":"1995","unstructured":"Perrilo R, Tamburro C, Regenstein F, Balart L, Bodenheimer H, Silva M, Schiff E, Bodicky C, Miller B, Denham C, Brodeur C, Roach K, Albrecht J (1995) Low dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus. Gastroenterology 109:908\u2013916","journal-title":"Gastroenterology"},{"key":"384_CR9","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","volume":"329","author":"D Samuel","year":"1993","unstructured":"Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H (1993) Liver transplantation in European patients with hepatitis B surface antigen. N Engl J Med 329:1842\u20131847","journal-title":"N Engl J Med"},{"key":"384_CR10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM199807093390201","volume":"339","author":"C-L Lai","year":"1998","unstructured":"Lai C-L, Chien R-N, Leung NWY, Chang T-T, Guan R, Tai D-R, Ng K-Y, Wu P-C, Dent JC, Barber J, Stephenson SL, Gray DF, Asia Hepatitis lamivudine Study Group (1998) A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 339:61\u201368","journal-title":"N Engl J Med"},{"key":"384_CR11","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199910213411702","volume":"341","author":"JL Dienstag","year":"1999","unstructured":"Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann H-WL, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA, The U.S. Lamivudine Investigator Group (1999) Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 341:1256\u20131263","journal-title":"N Engl J Med"},{"key":"384_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","volume":"124","author":"JL Dienstag","year":"2003","unstructured":"Dienstag JL, Goldin RN, Heathcote EJ, Hann HW, Woessner M, Stephenson SL, Gardner S, Gray DF, Schiff ER (2003) Histological outcome during long-term lamivudine therapy. Gastroenterology 124:105\u2013107","journal-title":"Gastroenterology"},{"key":"384_CR13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.510240339","volume":"24","author":"R Ling","year":"1996","unstructured":"Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ (1996) Selection of mutation in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 24:711\u2013713","journal-title":"Hepatology"},{"key":"384_CR14","first-page":"714","volume":"24","author":"GA Tipples","year":"1996","unstructured":"Tipples GA, Ma MM, Fisher KP, Bain VG, Kneteaman NW, Tyrrell DL (1996) Mutation in the HBV-RNA dependent DNA polymerase confers resistance to lamivudine in\u00a0vivo. Hepatology 24:714\u2013717","journal-title":"Hepatology"},{"key":"384_CR15","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/jhep.2000.19622","volume":"32","author":"AS Lok","year":"2000","unstructured":"Lok AS, Hussain M, Cursano C, Margotti M, Gramenzi A, Grazi GL, Jovine E, Benardi M, Andreone P (2000) Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy. Hepatology 32:1145\u20131153","journal-title":"Hepatology"},{"key":"384_CR16","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1053\/jhep.2001.25084","volume":"33","author":"NW Leung","year":"2001","unstructured":"Leung NW, Lai CL, Chang TT, Guan R, Lee CM, Ng KY, Lim SG, Wu PC, Dent JC, Edmondson S, Condreay LD, Chien RN, On behalf of the Asia Hepatitis Lamivudine Study Group (2001) Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e seroconversion rates: results after 3\u00a0years of therapy. Hepatology 33:1527\u20131532","journal-title":"Hepatology"},{"key":"384_CR17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1086\/368083","volume":"36","author":"CL Lai","year":"2003","unstructured":"Lai CL, Dienstag J, Schiff E, Leung NW, Atkins M, Hunt C, Brown N, Woessner M, Boehme R, Condreay L (2003) Prevalence and correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis 36:687\u2013696","journal-title":"Clin Infect Dis"},{"key":"384_CR18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/hep.510290340","volume":"29","author":"SK Ono-Nita","year":"1999","unstructured":"Ono-Nita SK, Kato N, Shiratori Y, Masaki T, Lan KH, Carrilho FJ, Omata M (1999) YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: a study by in\u00a0vitro full-length viral DNA transfection. Hepatology 29:939\u2013945","journal-title":"Hepatology"},{"key":"384_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1572-0241.2001.03501.x","volume":"95","author":"R Bruno","year":"2001","unstructured":"Bruno R, Sacchi P, Filice C, Filice G (2001) Acute liver failure during lamivudine treatment in a hepatitis B cirrhotic patient. Am J Gastroenterol 95:265","journal-title":"Am J Gastroenterol"},{"key":"384_CR20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/003655202317284309","volume":"27","author":"JH Wang","year":"2002","unstructured":"Wang JH, Lu SN, Lee CM, Lee JF, Chou YP (2002) Fatal hepatic failure after the emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis. Scand J Gastroenterol 27:366\u2013369","journal-title":"Scand J Gastroenterol"},{"key":"384_CR21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1023\/B:DDAS.0000017455.39171.56","volume":"49","author":"R Kuwahara","year":"2004","unstructured":"Kuwahara R, Kumashiro R, Inoue H, Tanabe R, Tanaka E, Hino T, Ide T, Koga Y, Sata M (2004) Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains. Dig Dis Sci 49:300\u2013303","journal-title":"Dig Dis Sci"},{"key":"384_CR22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510300221","volume":"30","author":"YF Liaw","year":"1999","unstructured":"Liaw YF, Chien RN, Yhe CT, Tsai SL, Chu CM (1999) Acute exacerbation and hepatitis B clearance after emergence of YMDD mutation during lamivudine therapy. Hepatology 30:567\u2013572","journal-title":"Hepatology"},{"key":"384_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1386-6346(99)00061-3","volume":"17","author":"S Kobayashi","year":"2000","unstructured":"Kobayashi S, Shimada K, Suzuki H, Tanikawa K, Sata M (2000) Development of a new method for detecting a mutation in the gene coding hepatitis B virus reverse transcriptase active site (YMDD motif). Hepatol Res 17:31\u201342","journal-title":"Hepatol Res"},{"key":"384_CR24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.510310130","volume":"31","author":"J Villeneuve","year":"2000","unstructured":"Villeneuve J, Condreay LD, Willems B, Pomier-Layrargues G, Fenyves D, Bilodeau M, Leduc R, Peltekian K, Wong F, Margulies M, Heathcote EJ (2000) Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 31:207\u2013210","journal-title":"Hepatology"},{"key":"384_CR25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0168-8278(00)80371-2","volume":"33","author":"FY Yao","year":"2000","unstructured":"Yao FY, Bass NM (2000) Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection. J Hepatol 33:301\u2013307","journal-title":"J Hepatol"},{"key":"384_CR26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/jhep.2001.26512","volume":"34","author":"FY Yao","year":"2001","unstructured":"Yao FY, Terrault NA, Freise C, Maslow L, Bass NM (2001) Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and activity replicating hepatitis B infection awaiting liver transplantation: a comparative study using matched, untreated cohort. Hepatology 34:411\u2013416","journal-title":"Hepatology"},{"key":"384_CR27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0168-8278(00)80372-4","volume":"33","author":"D Kapoor","year":"2000","unstructured":"Kapoor D, Guptan RC, Wakil SM, Kazim SM, Kaul R, Agarwal SR, Raisuddin S, Hasnain SE, Sarin SK (2000) Beneficial effect of lamivudine in hepatitis B virus related decompensated cirrhosis. J Hepatol 33:308\u2013312","journal-title":"J Hepatol"},{"key":"384_CR28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/jlts.2002.32983","volume":"8","author":"RJ Fontana","year":"2002","unstructured":"Fontana RJ, Keefe EB, Carey W, Fried M, Reddy R, Kowdley KV, Soldevila-Pico C, McClure LA, Lok ASF, for the National Institutes of Health Hepatitis B Virus Orthotopic Liver Transplantation Study Group (2002) Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl 8:433\u2013439","journal-title":"Liver Transpl"},{"key":"384_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1572-0241.2003.04021.x","volume":"99","author":"S Manolakopoulos","year":"2004","unstructured":"Manolakopoulos S, Karatapanis S, Elefsiniotis J, Mathou N, Vlachogiannakos J, Iliadou E, Kougioumtzan A, Economou M, Triantos C, Tzourmakliotis D, Avgerinos A (2004) Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection. Am J Gastroenterol 99:57\u201363","journal-title":"Am J Gastroenterol"},{"key":"384_CR30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/jhep.2001.21554","volume":"33","author":"RP Pelliro","year":"2001","unstructured":"Pelliro RP, Wright T, Rakela J, Levy G, Schiff E, Gish R, Martin P, Dienstag J, Adams P, Dickson R, Anschuetz G, Bell S, Condreay L, Brown N, The Lamivudine North American Transplant Group (2001) A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology 33:424\u2013432","journal-title":"Hepatology"},{"key":"384_CR31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/gast.1997.v113.pm9352863","volume":"113","author":"F Oberti","year":"1997","unstructured":"Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, Gallois Y, Rifflet MY, Penneau-Fontbonne D, Cales P (1997) Noninvasive diagnosis of hepatic fibrosis and cirrhosis. Gastroenterology 113:1609\u20131616","journal-title":"Gastroenterology"},{"key":"384_CR32","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0016-5085(88)80022-2","volume":"95","author":"AL Williams","year":"1988","unstructured":"Williams AL, Hoofnagle JH (1988) Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 95:734\u2013739","journal-title":"Gastroenterology"},{"key":"384_CR33","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1023\/A:1026609231094","volume":"44","author":"E Giannini","year":"1999","unstructured":"Giannini E, Botta F, Fasoli A, Ceppa P, Risso D, Lantieri PB, Celle G, Testa R (1999) Progressive liver functional impairment is associated with an increase in AST\/ALT ratio. Dig Dis Sci 44:1249\u20131253","journal-title":"Dig Dis Sci"},{"key":"384_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.510240111","volume":"24","author":"PE Ballmer","year":"1996","unstructured":"Ballmer PE, Reichen J, McNurlan MA, Sterchi AB, Anderson SE, Garlick PJ (1996) Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver. Hepatology 24:53\u201359","journal-title":"Hepatology"},{"key":"384_CR35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.510250128","volume":"25","author":"H Barle","year":"1997","unstructured":"Barle H, Nyberg B, Essen P, Anderson K, McNurlan MA, Wernerman J, Garlick PJ (1997) The synthesis rates of total liver protein and plasma albumin determined simultaneously in\u00a0vivo in humans. Hepatology 25:154\u2013158","journal-title":"Hepatology"},{"key":"384_CR36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa021812","volume":"348","author":"SJ Hadziyannis","year":"2003","unstructured":"Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL, for the Adefovir Dipivoxil 438 Study Group (2003) Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 348:800\u2013807","journal-title":"N Engl J Med"},{"key":"384_CR37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","volume":"348","author":"P Marcellin","year":"2003","unstructured":"Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL, for the Adefovir Dipivoxil 437 Study Group (2003) Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 348:808\u2013816","journal-title":"N Engl J Med"},{"key":"384_CR38","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1172\/JCI5882","volume":"103","author":"SK Ono-Nita","year":"1999","unstructured":"Ono-Nita SK, Kato N, Shiratori Y, Lan KH, Yoshida H, Carrilho FJ, Omata M (1999) Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors. J Clin Invest 103:1635\u20131640","journal-title":"J Clin Invest"},{"key":"384_CR39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0016-5085(03)00700-5","volume":"125","author":"C Westland","year":"2003","unstructured":"Westland C, Delaney IV W, Yang H, Chen SS, Marcellin P, Hadziyannis S, Gish R, Fry J, Brosgart C, Bibbs C, Miller M, Xiong S (2003) Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil. Gastroenterology 125:107\u2013116","journal-title":"Gastroenterology"},{"key":"384_CR40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2003.10.050","volume":"126","author":"R Perrillo","year":"2004","unstructured":"Perrillo R, Hann HW, Mutimer D, Willems B, Leung N, Lee WM, Moorat A, Gardner S, Woessner M, Bourne E, Brosgart CL, Schiff E (2004) Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology 126:81\u201390","journal-title":"Gastroenterology"},{"key":"384_CR41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0016-5085(03)00939-9","volume":"125","author":"P Augus","year":"2003","unstructured":"Augus P, Vaughan R, Xiong S, Yang H, Delaney W, Gibbs C, Brosgart C, Colledge D, Edwards R, Ayres A, Bartholomeusz A, Locarnini S (2003) Resistance to adefovir dipivoxil therapy associated with the selection of novel mutation in the HBV polymerase. Gastroenterology 125:292\u2013297","journal-title":"Gastroenterology"},{"key":"384_CR42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.gastro.2003.10.051","volume":"126","author":"MG Peters","year":"2004","unstructured":"Peters MG, Hann HW, Martin P, Heathcote EJ, Buggisch P, Rubin R, Bourliere M, Kowdley K, Trepo C, Gray DF, Sullivan M, Kleber K, Ebrahimi R, Xiong S, Brosgart CL, for the GS\u201300\u2013461 study group (2004) Adefovir dipivoxil alone or combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology 126:91\u2013101","journal-title":"Gastroenterology"},{"key":"384_CR43","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/gast.2002.37058","volume":"123","author":"CL Lai","year":"2002","unstructured":"Lai CL, Rosmawati M, Lao J, Vlierberghe HV, Anderson FH, Thomas N, Dehertogh D (2002) Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology 123:1831\u20131838","journal-title":"Gastroenterology"},{"issue":"suppl","key":"384_CR44","first-page":"656A","volume":"40","author":"M Rosmawati","year":"2004","unstructured":"Rosmawati M, Schiff E, Parana R, Sievert W, Zhu J, Cross A, Dehertogh D, Apelian D, for the BEHoLD Study Group (2004) ntecavir is superior to lamivudine at reducing HBV DNA in patients with chronic hepatitis B regardless of baseline alanine aminotransferase levels. Hepatology 40(suppl):656A","journal-title":"Hepatology"},{"issue":"suppl","key":"384_CR45","first-page":"664A","volume":"40","author":"M Shermann","year":"2004","unstructured":"Shermann M, Yurdaydin C, Sollano J, Silva M, Goodman Z, Chen L, Cross A, Dehertogh D, Hindes R, for the BEHoLD Study Group (2004) Entecavir is superior to continued lamivudine for the treatment of lamivudine-refractory, HBeAg(+) chronic hepatitis B: results of phase III study ETV\u2013026. Hepatology 40(suppl):664A","journal-title":"Hepatology"},{"key":"384_CR46","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.20464","volume":"40","author":"F Bommel van","year":"2004","unstructured":"van Bommel F, Wunsche T, Mauss S, Reinke P, Bergk A, Schurmann D, Wiedenmann B, Berg T (2004) Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. Hepatology 40:1421\u20131425","journal-title":"Hepatology"},{"key":"384_CR47","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","volume":"48","author":"DJ Tenney","year":"2004","unstructured":"Tenney DJ, Levine SM, Rose RE, Walsh AW, Weinheimer SP, Discotto L, Plym M, Pokornowski K, Yu CF, Angus P, Ayres A, Bartholomeusz A, Sievert W, Thompson G, Warner N, Locarnini S, Colonno RJ (2004) Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant lamivudine. Antimicrob Agents Chemother 48:3498\u20133507","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-008-0384-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0384-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T23:58:13Z","timestamp":1738281493000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-008-0384-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,10]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1007\/s10620-008-0384-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2008,7,10]]}}}